Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 49 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 62 | 2,530−1.6%/yr | −1.6%/yr | 2.30.9× | 4% | 2,680 in 2030+1%/yr |
| Lumbar fusion | 40 | 1,764+6.8%/yr | +6.8%/yr | 1.60.8× | 11% | 2,120 in 2030+3.1%/yr |
| Cervical fusion & disc arthroplasty | 15 | 957+0.5%/yr | +0.5%/yr | 0.90.8× | 0% | 1,050 in 2030+1.5%/yr |
| Kyphoplasty & vertebroplasty | 6 | 624−5.3%/yr | −5.3%/yr | 0.60.7× | 59% | 630 in 2030+0.1%/yr |
| SI joint fusion | 3 | 157+9.2%/yr | +9.2%/yr | 0.11.3× | 100% | 260 in 2030+9.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 590 | 129,243−0.9%/yr | −0.9%/yr | 118.71.4× | 49% | 147,900 in 2030+2.3%/yr |
| Skin substitutes & wound grafts | 47 | 11,826+17%/yr | +17%/yr | 7.71.7× | 65% | 21,200 in 2030+10%/yr |
| Bone graft & orthobiologics | 3 | 173−18%/yr | −18%/yr | 0.20.3× | 1% | 170 in 2030−0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 112 | 6,842−0.4%/yr | −0.4%/yr | 6.30.8× | 86% | 9,070 in 2030+4.8%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 8 | 739+5.9%/yr | +5.9%/yr | 0.70.9× | 58% | 950 in 2030+4.2%/yr |
| Spinal cord & DRG stimulation | 12 | 392−5%/yr | −5%/yr | 0.40.9× | 70% | 450 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 55 | 8,709+2.3%/yr | +2.3%/yr | 8.01.8× | 77% | 12,700 in 2030+6.4%/yr |
| Dialysis access | 58 | 7,071−13%/yr | −13%/yr | 7.01.3× | 70% | 7,590 in 2030+1.2%/yr |
| Superficial venous ablation | 70 | 4,906−2.3%/yr | −2.3%/yr | 4.51.4× | 97% | 6,260 in 2030+4.1%/yr |
| Thrombectomy, IVC filters & venous stents | 25 | 1,782+1%/yr | +1%/yr | 1.71.3× | 28% | 1,690 in 2030−0.8%/yr |
| Carotid revascularization | 26 | 1,073−1.9%/yr | −1.9%/yr | 1.01.0× | 0% | 1,090 in 2030+0.2%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 400−7.7%/yr | −7.7%/yr | 0.40.9× | 0% | 360 in 2030−1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 76 | 5,785−0.6%/yr | −0.6%/yr | 5.81.0× | 4% | 6,020 in 2030+0.7%/yr |
| Cholecystectomy & appendectomy | 81 | 3,400−3.2%/yr | −3.2%/yr | 3.30.9× | 1% | 3,540 in 2030+0.7%/yr |
| Colorectal resection | 8 | 1,527−3%/yr | −3%/yr | 1.50.9× | 0% | 1,740 in 2030+2.2%/yr |
| Antireflux & hiatal hernia surgery | 7 | 492+0.3%/yr | +0.3%/yr | 0.50.7× | 0% | 540 in 2030+1.6%/yr |
| Breast reconstruction | 1 | 481−3.3%/yr | −3.3%/yr | 0.51.1× | 0% | 370 in 2030−4.1%/yr |
| Bariatric surgery | 0 | 168−20%/yr | −20%/yr | 0.20.9× | 0% | 120 in 2030−5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 53 | 6,600−1.2%/yr | −1.2%/yr | 6.31.6× | 53% | 5,800 in 2030−2.1%/yr |
| Kidney stone management | 109 | 6,001+1.1%/yr | +1.1%/yr | 5.81.0× | 31% | 7,770 in 2030+4.4%/yr |
| Hysterectomy, hysteroscopy & ablation | 25 | 2,622+0.6%/yr | +0.6%/yr | 2.70.8× | 20% | 3,090 in 2030+2.8%/yr |
| Incontinence, prolapse & sacral neuromodulation | 26 | 1,784−4.1%/yr | −4.1%/yr | 1.70.9× | 9% | 1,880 in 2030+0.9%/yr |
| Prostatectomy & nephrectomy | 9 | 867+0.5%/yr | +0.5%/yr | 0.90.7× | 0% | 1,060 in 2030+3.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 22 | 3,263+0.4%/yr | +0.4%/yr | 3.10.9× | 94% | 4,190 in 2030+4.2%/yr |
| Ear tubes & middle ear surgery | 2 | 258−4.6%/yr | −4.6%/yr | 0.21.0× | 100% | 200 in 2030−3.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 124 | 7,0630%/yr | 0%/yr | 7.10.8× | 39% | 8,480 in 2030+3.1%/yr |
| Tumor & fibroid embolization | 4 | 287+0.9%/yr | +0.9%/yr | 0.30.4× | 22% | 820 in 2030+19%/yr |
| Tumor ablation | 0 | 107−1.1%/yr | −1.1%/yr | 0.10.3× | 0% | 120 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 303 | 39,418+16%/yr | +16%/yr | 37.11.3× | 99% | 69,600 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 86 | 4,680−4.6%/yr | −4.6%/yr | 4.60.9× | 0% | 4,910 in 2030+0.8%/yr |
| LAA occlusion & loop recorders | 90 | 3,940+7.1%/yr | +7.1%/yr | 3.41.0× | 37% | 6,480 in 2030+8.7%/yr |
| EP ablation | 61 | 3,055+5.7%/yr | +5.7%/yr | 2.50.7× | 0% | 5,460 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 172 | 6,009−4.6%/yr | −4.6%/yr | 4.91.0× | 0% | 7,900 in 2030+4.7%/yr |
| Structural heart (TAVR, TEER) | 71 | 1,653+2.7%/yr | +2.7%/yr | 1.40.7× | 0% | 2,140 in 2030+4.4%/yr |
| Mechanical circulatory support | 1 | 507+0.1%/yr | +0.1%/yr | 0.50.8× | 0% | 870 in 2030+9.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 13 | 399+11%/yr | +11%/yr | 0.40.7× | 0% | 600 in 2030+7.1%/yr |
| Stroke thrombectomy | 15 | 346+3.2%/yr | +3.2%/yr | 0.30.7× | 0% | 330 in 2030−1%/yr |
| DBS & VNS | 4 | 206+7.7%/yr | +7.7%/yr | 0.20.7× | 0% | 280 in 2030+5.4%/yr |
| CSF shunts | 0 | 134−11%/yr | −11%/yr | 0.10.6× | 0% | 120 in 2030−1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 259 | 44,451−1.6%/yr | −1.6%/yr | 41.80.8× | 95% | 46,300 in 2030+0.7%/yr |
| Vitreoretinal surgery | 23 | 1,908−1.3%/yr | −1.3%/yr | 1.80.9× | 56% | 1,990 in 2030+0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 581 | 123,352−1%/yr | −1%/yr | 121.51.0× | 59% | 138,300 in 2030+1.9%/yr |
| ERCP & endoscopic ultrasound | 46 | 3,131−1%/yr | −1%/yr | 3.00.8× | 3% | 3,440 in 2030+1.6%/yr |
| Bronchoscopy & lung nodule | 36 | 2,104+9.9%/yr | +9.9%/yr | 2.00.7× | 0% | 4,020 in 2030+11%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.